Latest News in the pharma Industry

Research & Development

FDA accepts BLA for avelumab for the treatment of metastatic urothelial carcinoma for Priority Review

FDA accepts BLA for avelumab for the treatment of metastatic urothelial carcinoma for Priority Review

28 Feb 2017

Second Biologics License Application accepted by the FDA for avelumab.

Read more 
CHMP recommends EU Conditional Marketing Authorisation for Natpar for patients with chronic hypoparathyroidism

CHMP recommends EU Conditional Marketing Authorisation for Natpar for patients with chronic hypoparathyroidism

27 Feb 2017

If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment.

Read more 
Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin

Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin

26 Feb 2017

Compared with warfarin, Pradaxa was associated with a 26% reduced risk of stroke and a 20% reduced risk of major bleeding.

Read more 
SGS platform provides modeling and simulation solutions for clinical trials

SGS platform provides modeling and simulation solutions for clinical trials

23 Feb 2017

Tool explores the time course of drug exposure, biomarker response and outcome.

Read more 
Updated Phase I Data show Bavarian Nordic's vaccine candidate induces broad and durable immune response against RSV

Updated Phase I Data show Bavarian Nordic's vaccine candidate induces broad and durable immune response against RSV

23 Feb 2017

Antibody levels maintained against multiple targets 6 months post vaccination.

Read more 
NIH begins study of vaccine to protect against mosquito-borne diseases

NIH begins study of vaccine to protect against mosquito-borne diseases

22 Feb 2017

Experimental vaccine targets mosquito saliva.

Read more 
Cell lines and media for difficult to culture tumour types

Cell lines and media for difficult to culture tumour types

22 Feb 2017

Aids R&D initiatives to advance precision medicine.

Read more 
Can yeast rise to the challenge of curing cancer?

Can yeast rise to the challenge of curing cancer?

21 Feb 2017

Modified baker’s yeasts cause an immune response and the production of lymphocyte killers, which detect and eliminate cancerous cells.

Read more 
Innova Biosciences introduces Magnetic Conjugation Kit

Innova Biosciences introduces Magnetic Conjugation Kit

21 Feb 2017

New kit enables covalent conjugation of antibodies and proteins to magnetic particles.

Read more 
New data in Crohn’s disease patients shows similar efficacy and safety profiles for Inflectra and Remicade

New data in Crohn’s disease patients shows similar efficacy and safety profiles for Inflectra and Remicade

20 Feb 2017

Trial data further supports the existing clinical profile of CT-P13 in inflammatory bowel disease.

Read more 
Phase II study supports potential for Genentech’s Tecentriq plus Avastin for people with mRCC

Phase II study supports potential for Genentech’s Tecentriq plus Avastin for people with mRCC

19 Feb 2017

Study showed that people whose disease expressed PD-L1 and were treated with Tecentriq plus Avastin had a 36% reduction in the risk of their disease worsening

Read more 
FDA expands approval of Spiriva Respimat inhalation spray

FDA expands approval of Spiriva Respimat inhalation spray

16 Feb 2017

Steroid-free Spiriva Respimat now approved as asthma treatment for age 6 and older.

Read more